ANTX Competitors & Alternatives
Compare AN2 Therapeutics Inc with similar stocks in the same industry
Biotechnology
ANTX
Main Stock$5.81
Tradestie Score
47
Market Cap
$35.25M
Analyst Upside
+54.9%
Top Competitors
241 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NGNE
Neurogene, Inc. Common Stock
|
$38.63
|
$256.54M | - | 41 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$13.27
|
$240.89M | - | 38 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.33
|
$231.77M | - | 37 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$10.25
|
$227.00M | - | 35 | Compare |
|
CABA
Cabaletta Bio, Inc. Common Stock
|
$3.13
|
$211.28M | - | 36 | Compare |
|
SLS
SELLAS Life Sciences Group, Inc. Common Stock
|
$15.46
|
$211.22M | - | 37 | Compare |
|
ACRS
Aclaris Therapeutics, Inc.
|
$6.41
|
$202.58M | - | 38 | Compare |
|
CBIO
Crescent Biopharma, Inc. Common Stock
|
$17.15
|
$199.71M | - | 47 | Compare |
|
ASMB
Assembly Biosciences, Inc
|
$34.38
|
$188.81M | 27.0 | 41 | Compare |
|
FBRX
Forte Biosciences, Inc. Common Stock
|
$76.92
|
$180.53M | - | 47 | Compare |
More ANTX Analysis
Data updated: Aug 22, 2026 | Industry: Biotechnology (SIC 2834)
241 stocks in this industry